The DOI matches its Crossref record; 385 of the 385 references it cites were found in a registry or an index.
Cellular Senescence in Neurodegenerative Diseases
Open accessAbstract
Cellular senescence is a homeostatic biological process characterized by a permanent state of cell cycle arrest that can contribute to the decline of the regenerative potential and function of tissues. The increased presence of senescent cells in different neurodegenerative diseases suggests the contribution of senescence in the pathophysiology of these disorders. Although several factors can induce senescence, DNA damage, oxidative stress, neuroinflammation, and altered proteostasis have been shown to play a role in its onset. Oxidative stress contributes to accelerated aging and cognitive dysfunction stages affecting neurogenesis, neuronal differentiation, connectivity, and survival. During later life stages, it is implicated in the progression of cognitive decline, synapse loss, and neuronal degeneration. Also, neuroinflammation exacerbates oxidative stress, synaptic dysfunction, and neuronal death through the harmful effects of pro-inflammatory cytokines on cell proliferation and maturation. Both oxidative stress and neuroinflammation can induce DNA damage and alterations in DNA repair that, in turn, can exacerbate them. Another important feature associated with senescence is altered proteostasis. Because of the disruption in the function and balance of the proteome, senescence can modify the proper synthesis, folding, quality control, and degradation rate of proteins producing, in some diseases, misfolded proteins or aggregation of abnormal proteins. There is an extensive body of literature that associates cellular senescence with several neurodegenerative disorders including Alzheimer's disease (AD), Down syndrome (DS), and Parkinson's disease (PD). This review summarizes the evidence of the shared neuropathological events in these neurodegenerative diseases and the implication of cellular senescence in their onset or aggravation. Understanding the role that cellular senescence plays in them could help to develop new therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–385 of 385
Pathways by Which Aβ Facilitates Tau Pathology
Blurton-Jones, M., & LaFerla, F. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025242 · Cited by 195
Telomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Epigenetic changes in the progression of Alzheimer's disease
Bradley-Whitman, M. A., & Lovell, M. A. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.005 · Cited by 193
Transient Activation of p53 in G2 Phase Is Sufficient to Induce Senescence
Krenning, L., Feringa, F. M., Shaltiel, I. A., van den Berg, J., & Medema, R. H. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.007 · Cited by 193
Cytokine Gene Expression as a Function of the Clinical Progression of Alzheimer Disease Dementia
Luterman, J. D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P. S., Mohs, R., & Pasinetti, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1153 · Cited by 192
Ferrer, I., Martinez, A., Blanco, R., Dalfó, E., & Carmona, M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0482-8 · Cited by 192
Proteostasis and neurodegeneration: The roles of proteasomal degradation and autophagy
Tanaka, K., & Matsuda, N. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.012 · Cited by 191
The Ubiquitin-Proteasome System and the Autophagic-Lysosomal System in Alzheimer Disease
Ihara, Y., Morishima-Kawashima, M., & Nixon, R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006361 · Cited by 190
Loss of Bif-1 Suppresses Bax/Bak Conformational Change and Mitochondrial Apoptosis
Takahashi, Y., Karbowski, M., Yamaguchi, H., Kazi, A., Wu, J., Sebti, S. M., Youle, R. J., & Wang, H.-G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9369-9382.2005 · Cited by 190
Gezen-Ak, D., Dursun, E., Hanağası, H., Bilgiç, B., Lohman, E., Araz, Ö. S., Atasoy, İ. L., Alaylıoğlu, M., Önal, B., Gürvit, H., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130497 · Cited by 188
Genetic and host factors for dementia in Down's syndrome
Schupf, N. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.405 · Cited by 188 · cited 2×
“…aging and AD pathology are thought to be the leading Frontiers in Cellular Neuroscience | www.frontiersin.org 8 February 2020 | Volume 14 | Article 16 causes of the earlier mortality of this population (Schupf and Sergievsky, 2002; Zigman and Lott, 2007; Prasher et al., 2008; Esbensen, 2010).”
BackgroundOxidative stress, cellular senescence and ageing
Pole, A., Dimri, M., & Dimri, G. P. (2016) · AIMS molecular science · doi:10.3934/molsci.2016.3.300 · Cited by 188
Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation.
Stein, G. H., Drullinger, L. F., Robetorye, R. S., Pereira-Smith, O. M., & Smith, J. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11012 · Cited by 185
Ogrodnik, M., Salmonowicz, H., & Gladyshev, V. N. (2019) · Aging Cell · doi:10.1111/acel.12841 · Cited by 184
The 5-Methylcytosine in DNA of Rats
Vanyushin, B. F., Nemirovsky, L. E., Klimenko, V. V., Vasiliev, V. K., & Belozersky, A. N. (1973) · Gerontology · doi:10.1159/000211967 · Cited by 184
Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
Bjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180 · cited 1×
“AD brains also present increased levels of other SASPs mediators: the metalloproteinases MMP1, MMP-3, and MMP-10 (Leake et al., 2000; Yoshiyama et al., 2000; Bjerke et al., 2011; Horstmann et al., 2018).”
BackgroundGitter, B. D., Cox, L. M., Rydel, R. E., & May, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10738 · Cited by 178
Health Conditions Associated with Aging and End of Life of Adults with Down Syndrome
Esbensen, A. J. (2010) · International Review of Research in Mental Retardation · doi:10.1016/s0074-7750(10)39004-5 · Cited by 176
Scalzo, P., Kümmer, A., Cardoso, F., & Teixeira, A. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.062 · Cited by 175
A brief overview of amyloids and Alzheimer's disease
Ow, S., & Dunstan, D. E. (2014) · Protein Science · doi:10.1002/pro.2524 · Cited by 175
DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease
Birch, J., Anderson, R. K., Correia-Melo, C., Jurk, D., Hewitt, G., Marques, F. M., Green, N. J., Moisey, E., Birrell, M. A., Belvisi, M. G., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00293.2015 · Cited by 174
Genomic integrity and the ageing brain
Chow, H.-M., & Herrup, K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4020 · Cited by 174
Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches
Fuster-Matanzo, A., Llorens-Martín, M., Hernández, F., & Ávila, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/260925 · Cited by 172
Vanyushin, B. F., Nemirovskiĭ, L. E., Klimenko, V. V., Vasiliev, V. K., & Belozersky, A. N. (1973) · PubMed · Cited by 172
Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities
Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171
Self-citationEvidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes
Myung, N.-H., Zhu, X., Kruman, I. I., Castellani, R. J., Petersen, R. B., Siedlak, S. L., Perry, G., Smith, M. A., & Lee, H.-G. (2008) · AGE · doi:10.1007/s11357-008-9050-7 · Cited by 170
Cipriani, S., Ferrer, I., Aronica, E., Kovacs, G. G., Verney, C., Nardelli, J., Khung, S., Delezoide, A.-L., Milenkovic, I., Rasika, S., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy096 · Cited by 169
Melki, R. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150543 · Cited by 169
Astrocytes aged in vitro show a decreased neuroprotective capacity
Pertusa, M., García‐Matas, S., Rodríguez‐Farré, E., Sanfeliu, C., & Cristòfol, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04369.x · Cited by 168
Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence
Nakamura, A. J., Chiang, Y. J., Hathcock, K. S., Horikawa, I., Sedelnikova, O. A., Hodes, R. J., & Bonner, W. M. (2008) · Epigenetics & Chromatin · doi:10.1186/1756-8935-1-6 · Cited by 168
Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes
Flanary, B. E., & Streit, W. J. (2004) · Glia · doi:10.1002/glia.10301 · Cited by 167
Aneuploidy: implications for protein homeostasis and disease
Oromendia, A. B., & Amon, A. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013391 · Cited by 166
Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165
Microglia Demonstrate Age-Dependent Interaction with Amyloid-β Fibrils
Floden, A. M., & Combs, C. K. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101014 · Cited by 162
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns
Sanchez-Mut, J. V., Heyn, H., Vidal, E., Morán, S., Sayols, S., Delgado‐Morales, R., Schultz, M. D., Ansoleaga, B., Garcia‐Esparcia, P., Pons‐Espinal, M., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.214 · Cited by 162
Mitochondria: Are they causal players in cellular senescence?
Correia-Melo, C., & Passos, J. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.017 · Cited by 160
Neuroanatomy of Down Syndrome in vivo: A Model of Preclinical Alzheimer’s Disease
Teipel, S. J., & Hampel, H. J. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9047-x · Cited by 159
Telomere shortening in neurological disorders: an abundance of unanswered questions
Eitan, E., Hutchison, E. R., & Mattson, M. P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.010 · Cited by 158 · cited 2×
“, 2014) while others do not find evidence of this alteration in PD (Guan et al., 2008; Wang et al., 2008; Eerola et al., 2010; Watfa et al., 2011; Maeda et al., 2012; Degerman et al., 2014; Eitan et al., 2014; Forero et al., 2016).”
BackgroundGlial cell dysregulation: a new perspective on Alzheimer disease
Rommy von Bernhardi, M. (2007) · Neurotoxicity Research · doi:10.1007/bf03033906 · Cited by 155
Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation
Qazi, T. J., Quan, Z., Mir, A., & Qing, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0357-6 · Cited by 153
Ferrón, S., Mira, H., Franco, S., Cano-Jaimez, M., Bellmunt, E., Ramírez, C., Fariñas, I., & Blasco, M. A. (2004) · Development · doi:10.1242/dev.01215 · Cited by 152
He, N., Jin, W.-L., Lok, K.-H., Wang, Y., Yin, M., & Wang, Z.-J. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.437 · Cited by 151
Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease
von Bernhardi, R., Cornejo, F., Parada, G. E., & Eugenín, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00426 · Cited by 149
X chromosome aneuploidy in the Alzheimer’s disease brain
Yurov, Y. B., Vorsanova, S. G., Liehr, T., Kolotii, A. D., & Iourov, I. Y. (2014) · Molecular Cytogenetics · doi:10.1186/1755-8166-7-20 · Cited by 146
Romanov, V. S., Поспелов, В. А., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 143
Histone Modifications in Senescence-Associated Resistance to Apoptosis by Oxidative Stress
Sanders, Y. Y., Liu, H., Zhang, X., Hecker, L., Bernard, K., Desai, L., Liu, G., & Thannickal, V. J. (2013) · Redox Biology · doi:10.1016/j.redox.2012.11.004 · Cited by 138
Jennings, B. J., Ozanne, S. E., & Hales, C. N. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3077 · Cited by 137
Telomere length is age-dependent and reduced in monocytes of Alzheimer patients
Hochstrasser, T., Marksteiner, J., & Humpel, C. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.012 · Cited by 137
Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease
Lukens, J. N., Deerlin, V. M. V., Clark, C. M., Xie, S. X., & Johnson, F. B. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.666 · Cited by 137
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Lockrow, J. P., Prakasam, A., Huang, P., Bimonte‐Nelson, H. A., Sambamurti, K., & Granholm, A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.021 · Cited by 136
Domenico, F. D., Coccia, R., Cocciolo, A., Murphy, M. P., Cenini, G., Head, E., Butterfield, D. A., Giorgi, A., Schininà, M. E., Mancuso, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.013 · Cited by 135
Cenini, G., Dowling, A. L. S., Beckett, T. L., Barone, E., Mancuso, C., Murphy, M. P., LeVine, H., Lott, I. T., Schmitt, F. A., Butterfield, D. A., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.001 · Cited by 135
Knock-In Reporter Mice Demonstrate that DNA Repair by Non-homologous End Joining Declines with Age
Vaidya, A. M., Mao, Z., Tian, X., Spencer, B., Seluanov, A., & Gorbunova, V. A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004511 · Cited by 134
Usp16 contributes to somatic stem-cell defects in Down’s syndrome
Adorno, M., Sikandar, S., Mitra, S. S., Kuo, A., Nicolis di Robilant, B., Haro-Acosta, V., Ouadah, Y., Quarta, M., Rodriguez, J., Qian, D., et al. (2013) · Nature · doi:10.1038/nature12530 · Cited by 134
Shichiri, M., Yoshida, Y., Ishida, N., Hagihara, Y., Iwahashi, H., Tamai, H., & Niki, E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.023 · Cited by 133
Gene expression profiling of replicative and induced senescence
Purcell, M., Kruger, A., & Tainsky, M. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973327 · Cited by 132
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
Hunter, C. L., Bachman, D., & Granholm, A. (2004) · Annals of Neurology · doi:10.1002/ana.20250 · Cited by 132
Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson’s Disease
Sepe, S., Milanese, C., Gabriels, S., Derks, K., Payán‐Gómez, C., van IJcken, W. F. J., Rijksen, Y., Nigg, A. L., Moreno, S., Cerri, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.071 · Cited by 131
Mitochondria, Telomeres and Telomerase Subunits
Zheng, Q., Huang, J., & Wang, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00274 · Cited by 130
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain
Yoshiyama, Y., Asahina, M., & Hattori, T. (2000) · Acta Neuropathologica · doi:10.1007/pl00007428 · Cited by 128 · cited 1×
“AD brains also present increased levels of other SASPs mediators: the metalloproteinases MMP1, MMP-3, and MMP-10 (Leake et al., 2000; Yoshiyama et al., 2000; Bjerke et al., 2011; Horstmann et al., 2018).”
BackgroundTelomere Shortening and Alzheimer’s Disease
Cai, Z., Yan, L., & Ratka, A. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8207-9 · Cited by 128
The DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
Lockrow, J. P., Boger, H. A., Bimonte‐Nelson, H. A., & Granholm, A. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.036 · Cited by 124
The epigenetic landscape of Alzheimer's disease
Lord, J., & Cruchaga, C. (2014) · Nature Neuroscience · doi:10.1038/nn.3792 · Cited by 122
Horstmann, S., Budig, L., Gardner, H., Koziol, J. A., Deuschle, M., Schilling, C., & Wagner, S. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000827 · Cited by 122
The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition
Steele, M. L., Stuchbury, G., & Münch, G. W. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.002 · Cited by 122
From cellular senescence to Alzheimer’s disease: The role of telomere shortening
Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., & Mecocci, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.003 · Cited by 121
Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation
Caldeira, C., Cunha, C., Vaz, A. R., Falcão, A. S., Barateiro, A., Seixas, E., Fernandes, A., & Brites, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00277 · Cited by 117
SnapShot: Genetics of Alzheimer’s Disease
Guerreiro, R. J., Brás, J., & Hardy, J. (2013) · Cell · doi:10.1016/j.cell.2013.10.037 · Cited by 117
Systemic DNA damage responses in aging and diseases
Ribezzo, F., Shiloh, Y., & Schumacher, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.005 · Cited by 116
Tumorigenesis in Down's syndrome: big lessons from a small chromosome
Nižetić, D., & Groet, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3355 · Cited by 115
The neuronal endosomal-lysosomal system in Alzheimer's disease
Nixon, R. A., Mathews, P. M., & Cataldo, A. M. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3114 · Cited by 114
Weirich, H. G., Weirich, H. G., Gruber, B., Schweiger, M. R., & Hirsch‐Kauffmann, M. (1994) · Mutation Research/DNAging · doi:10.1016/0921-8734(94)90006-x · Cited by 114
Cabelof, D. C., Raffoul, J. J., Yanamadala, S., Ganir, C., Guo, Z., & Heydari, A. R. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00003-9 · Cited by 114
Telomere shortening reduces Alzheimer’s disease amyloid pathology in mice
Rolyan, H., Scheffold, A., Heinrich, A., Begus-Nahrmann, Y., Langkopf, B. H., Hölter, S. M., Vogt-Weisenhorn, D. M., Liss, B., Wurst, W., Lie, D. C., et al. (2011) · Brain · doi:10.1093/brain/awr133 · Cited by 106
Aneuploid yeast strains exhibit defects in cell growth and passage through START
Thorburn, R. R., Gonzalez, C., Brar, G. A., Christen, S., Carlile, T. M., Ingolia, N. T., Sauer, U., Weissman, J. S., & Amon, A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-07-0520 · Cited by 106
Lüth, H. J., Holzer, M., Gertz, H.-J., & Arendt, T. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02178-2 · Cited by 105
Grodstein, F., van Oijen, M., Irizarry, M. C., Rosas, H. D., Hyman, B. T., Growdon, J. H., & De Vivo, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001590 · Cited by 104
Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
van Dijk, K. D., Persichetti, E., Chiasserini, D., Eusebi, P., Beccari, T., Calabresi, P., Berendse, H. W., Parnetti, L., & van de Berg, W. D. J. (2013) · Movement Disorders · doi:10.1002/mds.25495 · Cited by 101
Cabelof, D. C., Guo, Z., Raffoul, J. J., Sobol, R. W., Wilson, S. H., Richardson, A. G., & Heydari, A. R. (2003) · PubMed · Cited by 101
García-Cerro, S., Rueda, N., Vidal, V., Lantigua, S., & Martínez-Cué, C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.010 · Cited by 100
Self-citationSilva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
Sipos, E., Kurunczi, A., Kasza, Á., Horváth, J., Felszeghy, K., Laroche, S., Toldi, J., Párducz, Á., Penke, B., & Penke, Z. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.011 · Cited by 98
Valenti, D., Tullo, A., Caratozzolo, M. F., Merafina, R. S., Scartezzini, P., Marra, E., & Vacca, R. A. (2010) · Biochemical Journal · doi:10.1042/bj20100581 · Cited by 98
Perluigi, M., di Domenico, F., Fiorini, A., Cocciolo, A., Giorgi, A., Foppoli, C., Butterfield, D. A., Giorlandino, M., Giorlandino, C., Eugenia Schininà, M., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000121 · Cited by 97
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
Leake, A., Morris, C. M., & Whateley, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01418-x · Cited by 95
Ott, B. R., Jones, R. N., Daiello, L. A., de la Monte, S. M., Stopa, E. G., Johanson, C. E., Denby, C., & Grammas, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00245 · Cited by 91
A Percentage Analysis of the Telomere Length in Parkinson's Disease Patients
Guan, J. Z., Maeda, T., Sugano, M., Oyama, J.-I., Higuchi, Y., Suzuki, T., & Makino, N. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.5.467 · Cited by 91
Prasher, V. P., Sajith, S. G., Rees, S. D., Patel, A., Tewari, S., Schupf, N., & Zigman, W. B. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2039 · Cited by 90
Wei, Z., Chen, X.-C., Song, Y., Pan, X.-D., Dai, X.-M., Zhang, J., Cui, X.-L., Wu, X.-L., & Zhu, Y.-G. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.186646 · Cited by 89
Telomere length and risk of Parkinson's disease
Wang, H., Chen, H., Gao, X., McGrath, M., Deer, D., Vivo, I. D., Schwarzschild, M. A., & Ascherio, A. (2007) · Movement Disorders · doi:10.1002/mds.21867 · Cited by 87
ATF6α regulates morphological changes associated with senescence in human fibroblasts
Druelle, C., Drullion, C., Deslé, J., Martin, N., Saas, L., Cormenier, J., Malaquin, N., Huot, L., Slomianny, C., Bouali, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11505 · Cited by 87
Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain
Al‐Mashhadi, S., Simpson, J. E., Heath, P. R., Dickman, M., Forster, G., Matthews, F. E., Brayne, C., Ince, P. G., Wharton, S. B., & Medical Research Council Cognitive Function and Ageing Study (2015) · Brain Pathology · doi:10.1111/bpa.12216 · Cited by 85
Mansour, H., Chamberlain, C. G., Weible II, M. W., Hughes, S., Chu, Y., & Chan‐Ling, T. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00402.x · Cited by 84
Yang, N., & Sen, P. (2018) · Aging · doi:10.18632/aging.101617 · Cited by 83
Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
Esposito, M. M., & Sherr, G. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00476 · Cited by 83
Telomere length correlations among somatic tissues in adult zebra finches
Reichert, S., Criscuolo, F., Verinaud, E., Zahn, S., & Massemin, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081496 · Cited by 81
Loss of MECP2 Leads to Activation of P53 and Neuronal Senescence
Ohashi, M., Korsakova, E., Allen, D., Lee, P., Fu, K., Vargas, B. S., Cinkornpumin, J., Salas, C., Park, J. C., Germanguz, I., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.001 · Cited by 80 · cited 1×
“Senescence of these cell types have been implicated in the etiopathology of several neurodegenerative diseases (Streit et al., 2004, 2009; Conde and Streit, 2006; Baker et al., 2011; Bhat et al., 2012; He et al., 2013; Nasrabady et al., 2018; Ohashi et al., 2018), including Alzheimer’s disease (AD), Parkinson Disease…”
BackgroundYanagi, S., Tsubouchi, H., Miura, A., Matsuo, A., Matsumoto, N., & Nakazato, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030503 · Cited by 80
Evans, R., Wyllie, F. S., Wynford‐Thomas, D., Kipling, D., & Jones, C. J. (2003) · PubMed · Cited by 79
Galbiati, A., Beauséjour, C., & d'Adda di Fagagna, F. (2017) · Aging Cell · doi:10.1111/acel.12573 · Cited by 79
Corrales, A., Martinez, P. M., García-Cerro, S., Vidal, V., García, E., Flórez, J., Sánchez‐Barceló, E. J., Martínez‐Cué, C., & Rueda, N. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12037 · Cited by 78
Self-citationPositive and negative effects of cellular senescence during female reproductive aging and pregnancy
Velarde, M. C., & Menon, R. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0018 · Cited by 76
Di Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., Blarzino, C., Schmitt, F. A., Head, E., Butterfield, D. A., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141254 · Cited by 75
Watfa, G., Dragonas, C., Brosche, T., Dittrich, R., Sieber, C. C., Alecu, C., Bénétos, A., & Nzietchueng, R. (2010) · The journal of nutrition health & aging · doi:10.1007/s12603-010-0275-7 · Cited by 75
Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease
Pitcairn, C., Wani, W. Y., & Mazzulli, J. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.008 · Cited by 75
Molecular insights into Parkinson's disease
Thomas, B., & Beal, M. F. (2011) · F1000 Medicine Reports · doi:10.3410/m3-7 · Cited by 74
Contestabile, A., Fila, T., Bartesaghi, R., & Ciani, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00168.x · Cited by 74
The interdependence of gene-regulatory elements and the 3D genome
Vermunt, M. W., Zhang, D., & Blobel, G. A. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201809040 · Cited by 74
Plasma membrane microdomains in aging and disease
Ohno‐Iwashita, Y., Shimada, Y., Hayashi, M., & Inomata, M. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00600.x · Cited by 73
The Link Between Epigenetic Clocks for Aging and Senescence
Wagner, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00303 · Cited by 73
Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome
Cabelof, D. C., Patel, H., Chen, Q., Remmen, H. V., Matherly, L. H., Ge, Y., & Taub, J. W. (2009) · Blood · doi:10.1182/blood-2008-11-190330 · Cited by 71
Llorens-Martín, M., Jurado‐Arjona, J., Fuster-Matanzo, A., Hernández, F., Rábano, A., & Ávila, J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.92 · Cited by 70
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinsons Disease
Rivero-Ríos, P., Madero-Pérez, Fernández, B., & Hilfiker, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030103027 · Cited by 69
A correlation between aging and DNA repair in human epidermal cells
Nette, E. G., Xi, Y.-P., Sun, Y.-K., Andrews, A. D., & King, D. W. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90114-3 · Cited by 66
Increased Sensitivity of Lymphocytes from People Over 65 to Cell Cycle Arrest and Chromosomal Damage
Staiano‐Coico, L., Darżynkiewicz, Z., Hefton, J. M., Dutkowski, R. T., Darlington, G., & Weksler, M. E. (1983) · Science · doi:10.1126/science.6828861 · Cited by 66
The burden of trisomy 21 disrupts the proteostasis network in Down syndrome
Aivazidis, S., Coughlan, C. M., Rauniyar, A. K., Jiang, H. L., Liggett, L. A., Maclean, K. N., & Roede, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176307 · Cited by 65
Chong, Y.-H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00936-3 · Cited by 64
Cormenier, J., Martin, N., Deslé, J., Salazar-Cardozo, C., Pourtier, A., Abbadie, C., & Pluquet, O. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.003 · Cited by 64
Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients
Scarabino, D., Broggio, E., Gambina, G., & Corbo, R. M. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.025 · Cited by 64
Alzheimer’s disease and the autophagic-lysosomal system
Chung, K. M., Hernández, N., Sproul, A. A., & Yu, W. H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.05.017 · Cited by 63
Naderi, J., Lopez, C., & Pandey, S. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.08.006 · Cited by 62
Guan, J.-Z., Guan, W.-P., Maeda, T., & Makino, N. (2011) · Gerontology · doi:10.1159/000327821 · Cited by 61
Zekry, D., Herrmann, F. R., Irminger‐Finger, I., Graf, C. E., Genet, C., Vitale, A.-M., Michel, J., Gold, G., & Krause, K. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.07.019 · Cited by 59
Mayer, P. J., Lange, C. S., Bradley, M. O., & Nichols, W. W. (1989) · Mutation Research/DNAging · doi:10.1016/0921-8734(89)90019-2 · Cited by 57
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 57
The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease
Nagy, Z. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00485.x · Cited by 56
Li, H., Hedmer, M., Wojdacz, T. K., Hossain, M. B., Lindh, C. H., Tinnerberg, H., Albin, M. C., & Bröberg, K. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21958 · Cited by 56
Busciglio, J. A., Pelsman, A., Helguera, P. R., Ashur‐Fabian, O., Pinhasov, A., Brenneman, D. E., & Gozes, I. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780618957 · Cited by 56
Corrales, A., Vidal, R., García-Cerro, S., Vidal, V., Martinez, P. M., García, E., Flórez, J., Sánchez‐Barceló, E. J., Martínez‐Cué, C., & Rueda, N. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12097 · Cited by 56
Self-citationRodríguez‐Sureda, V., García, Á. V., Sánchez, O., Audí, L., & Domínguez, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/509241 · Cited by 55
Telomeres in neurological disorders
Anitha, A., Thanseem, I., Vasu, M. M., Viswambharan, V., & Poovathinal, S. A. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.01.003 · Cited by 55
Association Between ApoE Phenotypes and Telomere Erosion in Alzheimer’s Disease
Takata, Y., Kikukawa, M., Hanyu, H., Koyama, S., Shimizu, S., Umahara, T., Sakurai, H., Iwamoto, T., Ohyashiki, K., & Ohyashiki, J. H. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr185 · Cited by 54
Reduced telomere length in neurodegenerative disorders may suggest shared biology
Kota, L. N., Bharath, S., Purushottam, M., Moily, N. S., Sivakumar, P. T., Varghese, M., Pal, P. K., & Jain, S. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13100240 · Cited by 53
Maeda, T., Guan, J. Z., Koyanagi, M., Higuchi, Y., & Makino, N. (2012) · Journal of Neurogenetics · doi:10.3109/01677063.2011.651665 · Cited by 53
Sabbagh, M. N., Fleisher, A., Chen, K., Rogers, J., Berk, C., Reiman, E., Pontecorvo, M., Mintun, M., Skovronsky, D., Jacobson, S. A., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.535 · Cited by 53
Rosi, S., Bélarbi, K., Ferguson, R. A., Fishman, K., Obenaus, A., Raber, J., & Fike, J. R. (2010) · Hippocampus · doi:10.1002/hipo.20920 · Cited by 51
No Evidence for Shorter Leukocyte Telomere Length in Parkinson's Disease Patients
Eerola, J., Kananen, L., Manninen, K., Hellström, O., Tienari, P. J., & Hovatta, I. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq125 · Cited by 50
Epigenetic Changes in Neurodegenerative Diseases
Kwon, M. J., Kim, S., Han, M., & Lee, S. B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0233 · Cited by 50
Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease
Martinez, A. N., López, N., González, C., & Hetz, C. A. (2019) · Biology of the Cell · doi:10.1111/boc.201800068 · Cited by 49
Wu, M., Ye, H., Shao, C., Zheng, X., Li, Q., Wang, L., Zhao, M., Lu, G., Chen, B., Zhang, J., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00111 · Cited by 48
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome
Contestabile, A., Fila, T., Cappellini, A., Bartesaghi, R., & Ciani, E. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00587.x · Cited by 47
Renani, P. G., Taheri, F., Rostami, D., Farahani, N., Abdolkarimi, H., Abdollahi, E., Taghizadeh, E., & Hayat, S. M. G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28622 · Cited by 45
Barbouti, A., Evangelou, K., Pateras, I. S., Papoudou-Bai, A., Patereli, A., Stefanaki, K., Rontogianni, D., Muñoz-Espín, D., Kanavaros, P., & Gorgoulis, V. G. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.02.005 · Cited by 44
Tiribuzi, R., Orlacchio, A., Crispoltoni, L., Maiotti, M., Zampolini, M., De Angeliz, M., Mecocci, P., Cecchetti, R., Bernardi, G., Datti, A., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-100525 · Cited by 43
Jenkins, E. C., Ye, L., Gu, H., Ni, S. A., Duncan, C. J., Velinov, M. T., Pang, D. I., Krinsky‐McHale, S. J., Zigman, W. B., Schupf, N., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.098 · Cited by 42
Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects
Kimura, M., Cao, X., Skurnick, J., Cody, M., Soteropoulos, P., & Aviv, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.023 · Cited by 42
Cleaver, J. E., Kaufmann, W. K., Kapp, L. N., & Park, S. D. (1983) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(83)90031-3 · Cited by 41
Senescence in the aging process
Faragher, R., McArdle, A., Willows, A. O. D., & Ostler, E. L. (2017) · F1000Research · doi:10.12688/f1000research.10903.1 · Cited by 41
Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration
Mendelsohn, A. R., & Larrick, J. W. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2155 · Cited by 41
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., Butterfield, D. A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151105 · Cited by 40
Ma, D., Stokes, K., Mahngar, K., Domazet-Damjanov, D., Sikorska, M., & Pandey, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.004 · Cited by 39
Progress in the genetic analysis of Parkinson’s disease
Singleton, A., & Hardy, J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz179 · Cited by 39
Acetylcholine and aromatic amine systems in postmortem brain of an infant with Down's syndrome
McGeer, E. G., Norman, M. G., Boyes, B. E., OʼKusky, J. R., Suzuki, J., & McGeer, P. L. (1985) · Experimental Neurology · doi:10.1016/0014-4886(85)90184-0 · Cited by 37
Klocker, H., Schneider, R., Hj, B., Auer, B., Hirsch‐Kauffmann, M., & Schweiger, M. R. (1986) · PubMed · Cited by 37
Parisotto, E. B., Vidal, V., García-Cerro, S., Lantigua, S., Wilhelm Filho, D., Sanchez-Barceló, E. J., Martínez-Cué, C., & Rueda, N. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2008-8 · Cited by 37
Self-citationDegerman, S., Domellöf, M., Landfors, M., Linder, J., Lundin, M., Haraldsson, S., Elgh, E., Roos, G., & Forsgren, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113387 · Cited by 33
Park, J., Strock, C. J., Ball, D. W., & Nelkin, B. D. (2004) · Cytokine · doi:10.1016/j.cyto.2004.10.005 · Cited by 32
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice
Rueda, N., Vidal, V., García-Cerro, S., Narcís, J. O., Llorens-Martín, M., Corrales, A., Lantigua, S., Iglesias, M., Merino, J., Merino, R., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.008 · Cited by 32
Self-citationYates, S. C., Zafar, A., Rabai, E. M., Foxall, J. B., Nagy, S., Morrison, K. E., Clarke, C., Esiri, M. M., Christie, S., Smith, A. D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0114050 · Cited by 31 · cited 7×
“The other abnormal protein found in AD brains is hyperphosphorylated tau in the form of NFTs, which have been reported to induce senescence (Mendelsohn and Larrick, 2018).”
BackgroundInfluentialA concise review of human brain methylome during aging and neurodegenerative diseases
Prasad G, R., & Jho, E.-H. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.10.215 · Cited by 31
Senescence, Immortalization, and Apoptosis
Monti, D., Grassilli, E., Troiano, L., Cossarizza, A., Salvioli, S., Barbieri, D., AGNESINI, C., Bettuzzi, S., Ingletti, M. C., Corti, A., et al. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb27438.x · Cited by 31
Magini, A., Polchi, A., Tozzi, A., Tancini, B., Tantucci, M., Urbanelli, L., Borsello, T., Calabresi, P., & Emiliani, C. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.11.001 · Cited by 31
Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease
Winick‐Ng, W., & Rylett, R. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00060 · Cited by 31
Dysfunction of the ubiquitin–proteasome system in the cerebellum of aging Ts65Dn mice
Necchi, D., Lomoio, S., & Scherini, E. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.009 · Cited by 29
Hinterberger, M., Fischer, P., Huber, K., Krugluger, W., & Zehetmayer, S. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1721-z · Cited by 28
Telomeres in Trisomy 21 Amniocytes
Halevy, R. S., Biron‐Shental, T., Sharony, R., Fejgin, M. D., & Amiel, A. (2011) · Cytogenetic and Genome Research · doi:10.1159/000329714 · Cited by 26
Mayne, L. V. (1984) · Mutation Research/DNA Repair Reports · doi:10.1016/0167-8817(84)90023-3 · Cited by 26
Raji, N., Surekha, A., & Rao, K. S. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00062-1 · Cited by 24
Senescence in amniocytes and placentas from trisomy 21 pregnancies
Amiel, A., Fejgin, M. D., Liberman, M., Sharon, Y., Kidron, D., & Biron‐Shental, T. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.768982 · Cited by 24
Freidl, M., Gulesserian, T., Lübec, G., Fountoulakis, M., & Lubec, B. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_4 · Cited by 23
Biron‐Shental, T., Liberman, M., Sharvit, M., Halevy, R. S., & Amiel, A. (2015) · Gene · doi:10.1016/j.gene.2015.02.075 · Cited by 20
Epigenomic engineering for Down syndrome
Mentis, A. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.012 · Cited by 20
Siddiqui, M. S., Francois, M., Hecker, J., Faunt, J., Fenech, M. F., & Leifert, W. R. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.03.001 · Cited by 20
The role of mitochondria in longevity and healthspan
Brand, M. D. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-7 · Cited by 17
Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome
Pawlikowski, B. T., Betta, N. D., Elston, T. L., Williams, D. A., & Olwin, B. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-22342-5 · Cited by 17
Leukocyte Lysosomal Enzymes in Alzheimer's Disease and Down's Syndrome
Bognar, S. K., Rundek, T., Furač, I., Demarin, V., & Ćosović, Č. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.1.b16 · Cited by 15
Hematopoietic Stem Cells from Ts65Dn Mice Are Deficient in the Repair of DNA Double-Strand Breaks
Wang, Y., Chang, J., Shao, L., Feng, W., Luo, Y., Chow, M., Du, W., Meng, A., & Zhou, D. (2016) · Radiation Research · doi:10.1667/rr14407.1 · Cited by 13
Loss of DNA polymerase β induces cellular senescence
Ahmed, A. A., Smoczer, C., Pace, B. R., Patterson, D. W., & Cabelof, D. C. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22206 · Cited by 13
Cytokine and Chemokine Alterations in Down Syndrome
Roberson, R. B., Kuddo, T., Horowitz, K. M., et al. (2012) · American Journal of Perinatology · doi:10.1055/s-0032-1314892 · Cited by 11
Li, W., Wang, Z., Liu, S., Hu, Y., Yin, M., & Yang, L. (2016) · Stem Cells International · doi:10.1155/2016/7419389 · Cited by 11
AgNOR status in Down's syndrome infants and a plausible phenotype formation hypothesis
Demirtaş, H. (2009) · Micron · doi:10.1016/j.micron.2009.02.014 · Cited by 10
Aging and base excision repair: In need of a comprehensive approach
Cabelof, D. C. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.06.006 · Cited by 9
Research works printed but not linked: 10
- Agarwal, 1970, DNA polymerase activity as an index of lymphocyte stimulation: studies in Down’s syndrome, J. Clin. Invest., 49, 161, 10.1172/jci106215 · doi:10.1172/jci106215
- de Arruda Cardoso Smith, 2004, Telomeres on chromosome 21 and aging in lymphocytes and gingival fibroblasts from individuals with Down syndrome, J. Oral Sci., 46, 171, 10.2334/josnusd.46.171 · doi:10.2334/josnusd.46.171
- Dutkowski, 1985, Increased chromosomal instability in lymphocytes from elderly humans, Mutat. Res., 149, 505, 10.1016/0027-5107(85)90169-1 · doi:10.1016/0027-5107(85)90169-1
- Friedberg, 1985, DNA Repair.
- Hackett, 1981, Repair of lesions which cause premature termination of transcription in chicken embryo cells irradiated with ultraviolet light, Virology, 112, 752, 10.1016/0042-6822(81)90320-2 · doi:10.1016/0042-6822(81)90320-2
- Koliada, 2014, The study of telomere length in patients with Parkinson’s disease, Zh. Nevrol. Psikhiatr. Im. S S Korsakova, 114, 58
- Meager, 2004, Cytokines: interleukins, 115
- Meager, 2005, Viral inhibitors and immune response mediators: the interferons, 387
- Roth, 1989, Age-related decrease in an early step of DNA-repair of normal human lymphocytes exposed to ultraviolet-irradiation, Exp. Cell Res., 180, 171, 10.1016/0014-4827(89)90221-8 · DOI
- Tomac, 2001, Assignment of the mouse Park2 (PARKIN), the homologue to a new human Parkinson candidate gene, to the telomeric region of mouse 17A3.2–3.3, by in situ hybridization, Cytogenet. Cell Genet., 95, 120, 10.1159/000057032 · doi:10.1159/000057032
Cited by
Strategies for targeting senescent cells in human disease
Gasek, N. S., Kuchel, G. A., Kirkland, J. L., & Xu, M. (2021) · Nature Aging · doi:10.1038/s43587-021-00121-8 · Cited by 501
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Oxidative stress and mitochondrial impairment: Key drivers in neurodegenerative disorders
Wen, P., Sun, Z., Gou, F., Wang, J., Fan, Q., Zhao, D., & Yang, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102667 · Cited by 253
Inflammation and DNA damage: cause, effect or both
Pezone, A., Olivieri, F., Napoli, M. V., Procopio, A., Avvedimento, E. V., & Gabrielli, A. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00905-1 · Cited by 212
Matias, I., Diniz, L. P., Damico, I. V., Araujo, A. P. B., Neves, L. D. S., Vargas, G., Leite, R. E. P., Suemoto, C. K., Nitrini, R., Jacob‐Filho, W., et al. (2022) · Aging Cell · doi:10.1111/acel.13521 · Cited by 183
Metadata
- Authors
- Martínez-Cué, C., & Rueda, N.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-02-11
- Volume
- 14
- Pages
- 16-16
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W3006360897
- Cited by
- 281
- References
- 385
- FWCI
- 20.11
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Ministerio de Economía y Competitividad
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.